Quercetin: The Complete Ingredient Guide

What Is Quercetin?

Quercetin is a flavonoid, a class of plant pigment found widely across the food supply. It is one of the most abundant dietary polyphenols, occurring naturally in onions, apples, capers, broccoli, red grapes, and green tea. The word flavonoid comes from the Latin flavus, meaning yellow, and quercetin is responsible for the yellow-orange pigment in many of the plants that contain it.

Despite being common in food, quercetin presents a real absorption challenge. Standard quercetin from dietary sources or most supplements is poorly absorbed in the gut. Estimates put oral bioavailability at roughly 1 to 5 percent, meaning most of what you swallow never reaches systemic circulation. This matters because the research demonstrating quercetin's effects, particularly its senolytic and NAD+-preserving properties, is based on biologically active concentrations that standard dosing may not reliably achieve.

This bioavailability limitation has driven significant formulation work, discussed further below, to produce quercetin complexes that substantially improve absorption.

How Quercetin Works

Quercetin acts through several distinct molecular mechanisms, which is part of why its effects appear across so many different areas of biology.

Antioxidant activity

Quercetin scavenges free radicals and chelates metal ions that catalyse oxidative reactions. It also upregulates the body's own antioxidant enzymes, including superoxide dismutase and catalase, rather than simply acting as a direct neutraliser. This is an important distinction: compounds that stimulate endogenous antioxidant systems tend to produce more sustained protection than simple radical scavengers.

Anti-inflammatory signalling

Quercetin inhibits NF-kB, the master transcription factor governing pro-inflammatory gene expression. When NF-kB is active, it switches on the production of cytokines including TNF-alpha, IL-1beta, and IL-6. By suppressing NF-kB activation, quercetin reduces the inflammatory signal at source rather than blocking individual cytokines downstream. It also inhibits certain enzymes involved in the inflammatory cascade, including cyclooxygenase and lipoxygenase.

Senolytic activity

Quercetin selectively induces apoptosis in senescent cells, which are cells that have permanently stopped dividing but resist clearance and instead secrete a damaging cocktail of inflammatory signals. This property is covered in detail in the next section.

Quercetin as a Senolytic

Senescent cells accumulate with age in virtually every tissue. They are not simply inactive: they actively secrete pro-inflammatory cytokines, matrix-degrading enzymes, and growth factors collectively known as the senescence-associated secretory phenotype, or SASP. The SASP drives chronic low-grade inflammation, damages neighbouring cells, and contributes to multiple age-related conditions including fibrosis, cardiovascular decline, and impaired tissue regeneration.

Senolytics are compounds that selectively clear senescent cells while leaving healthy cells intact. Quercetin was identified as one of the first natural senolytics through work at the Mayo Clinic, where researchers showed it could selectively kill senescent cells in culture and reduce senescent cell burden in aged mice.

The most studied senolytic protocol combines quercetin with dasatinib, a cancer drug that also has senolytic properties. The combination, referred to as D+Q in the research literature, demonstrated clearance of senescent cells in human adipose tissue in a small but notable clinical trial, representing the first evidence of senolytic activity in living humans. Importantly, the protocol used an intermittent pulsed approach rather than daily dosing, reflecting the biology: senescent cells do not continuously replenish at the same rate, so pulse dosing allows clearance to occur and then allows the body time before the next cycle.

For longevity applications, the senolytic mechanism is significant. Reducing senescent cell load is one of the few interventions with direct mechanistic rationale for addressing a root cause of biological ageing rather than managing a downstream symptom.

Quercetin and NAD+ Synergy

One of the more underappreciated properties of quercetin is its ability to inhibit CD38, an enzyme that is the primary consumer of NAD+ in ageing tissues.

NAD+ levels decline significantly with age. The conventional explanation points to reduced biosynthesis, which is where NMN supplementation acts by supplying a direct precursor to NAD+ production. But biosynthesis is only one side of the equation. On the other side, NAD+ is continuously being consumed, and CD38 is the dominant consumer. CD38 is a glycohydrolase that degrades NAD+ and is expressed across many cell types, with expression increasing substantially with age, partly because CD38 is expressed on immune cells that accumulate as part of chronic low-grade inflammation.

Quercetin inhibits CD38 directly, reducing NAD+ degradation. In animal studies, CD38 inhibition has produced NAD+ increases comparable in magnitude to precursor supplementation. The implication is that combining NMN (which boosts NAD+ production) with quercetin (which reduces NAD+ breakdown via CD38 inhibition) addresses both sides of the NAD+ equation simultaneously.

This is the mechanistic basis for including quercetin alongside NMN rather than treating them as interchangeable or redundant. They act at different points in the same metabolic pathway.

Cardiovascular Benefits

Quercetin has been studied for its effects on blood pressure, endothelial function, and LDL oxidation across a number of human trials.

Blood pressure

A 2007 randomised controlled trial published in the Journal of Nutrition found that quercetin supplementation at 730mg per day for 28 days reduced systolic blood pressure by approximately 7 mmHg in participants with hypertension. Effects in normotensive individuals were not significant, suggesting the benefit is most relevant in people with elevated baseline blood pressure. A later meta-analysis confirmed a modest but consistent blood pressure-lowering effect from quercetin supplementation.

Endothelial function

Quercetin supports nitric oxide availability in the endothelium, the inner lining of blood vessels. Nitric oxide is essential for vascular tone and flexibility. Quercetin inhibits the enzyme that degrades nitric oxide and reduces oxidative stress in endothelial cells, both of which preserve nitric oxide bioavailability. Improved endothelial function translates to better vascular reactivity and reduced arterial stiffness.

LDL oxidation

Oxidised LDL is more atherogenic than unmodified LDL. Quercetin reduces LDL oxidation by protecting lipid particles from free radical damage. In vitro evidence is strong; in vivo human data are more modest, but consistent with the antioxidant mechanism.

Immune and Anti-inflammatory Effects

Beyond its NF-kB inhibition, quercetin has a well-documented role in modulating immune activity at several levels.

Cytokine modulation

Quercetin suppresses the production of TNF-alpha, IL-1beta, IL-6, and IL-8, key mediators of the acute inflammatory response and prominent components of the SASP secreted by senescent cells. This dual action, both direct cytokine suppression and senolytic clearance of the cells generating those cytokines, makes quercetin particularly relevant for addressing inflammaging, the chronic low-grade inflammatory state that characterises biological ageing.

Mast cell stabilisation

Quercetin stabilises mast cell membranes, reducing histamine and inflammatory mediator release. This is the mechanism behind its traditional use in seasonal allergy management and the basis for several clinical trials examining quercetin for allergic rhinitis. It inhibits IgE-mediated signalling and downstream mast cell degranulation, producing an antihistamine-like effect without binding directly to histamine receptors.

Quercetin Bioavailability

Standard quercetin aglycone, the free form most commonly found in supplements, has poor oral bioavailability. It dissolves poorly in water, is partially degraded in the gut, and much of what is absorbed undergoes rapid metabolism in the intestinal wall and liver before reaching systemic circulation.

• Quercetin phytosome: A patented form where quercetin is complexed with phosphatidylcholine from sunflower lecithin. Studies comparing quercetin phytosome to standard quercetin have shown bioavailability improvements in the range of 20 to 50 times.
• Quercetin glycosides: Quercetin attached to sugar molecules, as found naturally in foods. More water-soluble and absorbed via different intestinal transporters.
• Quercetin with piperine: Certain co-administration strategies improve absorption, though evidence is less consistent than for the phytosome form.

Dosage

For general antioxidant and anti-inflammatory effects, trials have used 500mg to 1000mg of quercetin per day. For senolytic protocols, the approach is typically intermittent: two consecutive days on followed by weeks off. The rationale is that senolytic activity does not require continuous dosing. Senescent cell clearance occurs during the active period, and the gap allows tissue homeostasis before the next cycle.

Side Effects and Safety

Quercetin has a generally good safety profile at doses used in clinical research. Adverse effects from trials at 500 to 1000mg per day are uncommon and typically mild. A few considerations apply at higher doses:

• Kidney stones: At doses above 1000mg per day, quercetin may theoretically increase oxalate load in those prone to calcium oxalate stones.
• Drug interactions: Quercetin inhibits CYP3A4 and CYP2C8, affecting plasma levels of medications metabolised by these pathways, including some statins and immunosuppressants.
• Thyroid medication: Separate doses by several hours if taking thyroid hormone replacement.
• Pregnancy: Insufficient safety data exist. Avoid unless advised by a clinician.

The NMN Bio Quercetin Formula

Quercetin appears in the NMN Bio Muscle Formula, chosen for two properties: its senolytic activity and its CD38 inhibition. The Muscle Formula targets the biology of muscle ageing, where senescent cell accumulation drives impaired repair and recovery. Quercetin addresses this while simultaneously reducing NAD+ degradation via CD38, reinforcing the NAD+ support from NMN in the formula.

NAD+ Brain uses fisetin rather than quercetin as its senolytic, because fisetin crosses the blood-brain barrier more readily. Quercetin's profile favours peripheral tissue applications, particularly muscle. These are not interchangeable choices: the difference reflects the distinct pharmacological properties of each compound and the tissue targets they are intended to reach.